3PBIOVIAN ranks among Spain’s 100 Best Companies to Work For
News and updates
All
Dámaso Molero Featured in PharmaBoardroom: Our Vision for 3PBIOVIAN’s Growth and Future, and the Evolution of Europe’s Biotech Sector
3PBIOVIAN Appoints Ponchi Kantt-Neaz as Global Executive Business Director, Marking a Milestone in its Commercial Strategy
3PBIOVIAN Contributes to Advancing Personalized Cancer Immunotherapies Through the PITÁGORAS Project
How to Prevail Over Common Bottlenecks in Recombinant Protein Development
The European CDMO Model, Powering Biologics Innovation
From Concept To Commercial Reality: Successful Upscaling Strategies For Viral Vector Manufacturing
Process development, scale-up and challenges of TM adenovirus GMP process in the iCELLis
Myths That Make Early CDMO Engagement Look Like A Risk
De-Risking AAV Production By Working With An End-To-End CDMO
GMP Recombinant Protein Manufacturing: Key Challenges and How to Address Them
Unlocking Flexible AAV Production: 3PBIOVIAN’s In-House Plasmids And Manufacturing Capacity
Vendor To Visionary: Transforming AAV Manufacturing
3PBIOVIAN reinforces its commitment to continuous learning through UPNA micro-credentials
3PBIOVIAN expands its mammalian capacity with a second 2,000 L bioreactor
Bio-Europe Fall